Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area jak stat signaling egfr'

Search results for: 'research area jak stat signaling egfr'

Items 101-110 of 110

Page
per page
  1. Deltarasin
    A3358 Deltarasin
    Target: Phosphodiesterases (PDEs)
    Summary: KRAS-PDEδ interaction inhibitor
      Soluble in DMSO
  2. GDC-0941
    A8210 GDC-0941
     10 Citation
    Target: PI3K
    Summary: PI3K inhibitor,potent and selective
      ≥25.7 mg/mL
  3. BMS 309403
    B7794 BMS 309403
     2 Citation
    Target: Fatty-acid-binding proteins (FABPs)
    Summary: FABP4 inhibitor,potent and selective
      insoluble in H2O; ≥18.15 mg/mL
  4. R428
    A8329 R428
     10 Citation
    Summary: Selective Axl inhibitor
      ≥25 mg/mL
  5. GDC-0449 (Vismodegib)
    A3021 GDC-0449 (Vismodegib)
     1 Citation
    Target: P-glycoprotein (P-gp)|Hedgehog
    Summary: Hedgehog antagonist,potent and selective
      ≥21.08 mg/mL
  6. PD 173074
    A8253 PD 173074
    Target: VEGFR|FGFR
    Summary: FGFR inhibitor
      ≥26.18 mg/mL
  7. Tivantinib (ARQ 197)
    A8325 Tivantinib (ARQ 197)
     2 Citation
    Target: MET
    Summary: C-Met inhibitor,non-ATP-competitive
      ≥18.47 mg/mL
  8. Saracatinib (AZD0530)
    A2133 Saracatinib (AZD0530)
     3 Citation
    Target: Src
    Summary: Src/Abl inhibitor,potent and selective
      ≥27.1 mg/mL
  9. Nintedanib (BIBF 1120)
    A8252 Nintedanib (BIBF 1120)
     3 Citation
    Target: VEGFR|PDGFR|FGFR
    Summary: VEGFR/PDGFR/FGFR inhibitor
      insoluble in H2O; insoluble in EtOH; ≥5.34 mg/mL
  10. R406
    A8546 R406
     1 Citation
    Target: Syk
    Summary: SYK inhibitor,potent and ATP-competitive
      ≥31.45 mg/mL

Items 101-110 of 110

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 2item
  2. Chromatin/Epigenetics 12item
  3. Metabolism 3item
  4. MAPK Signaling 19item
  5. Tyrosine Kinase 27item
  6. DNA Damage/DNA Repair 2item
  7. PI3K/Akt/mTOR Signaling 24item
  8. Ubiquitination/ Proteasome 1 item
  9. JAK/STAT Signaling 28item
  10. TGF-β / Smad Signaling 13item
  11. Stem Cell 13item
  12. Membrane Transporter/Ion Channel 1 item
  13. Endocrinology and Hormones 1 item
  14. Neuroscience 3item
  15. Obesity, Appetite Control & Diabetes 2item
  16. Other Signal Transduction 2item
  17. Immunology/Inflammation 1 item
  18. Cardiovascular 1 item
Reversibility
  1. Reversible 7item
  2. Irreversible 3item
Target
  1. Akt 4item
  2. PI3K 10item
  3. Raf 6item
  4. mTOR 6item
  5. Androgen Receptors 1 item
  6. FLT3 1 item
  7. GSK-3 5item
  8. P-glycoprotein (P-gp) 1 item
  9. VEGFR 6item
  10. PDGFR 3item
  11. Phosphodiesterases (PDEs) 1 item
  12. p38 4item
  13. PKB 1 item
  14. JNK 4item
  15. Bcr-Abl 1 item
  16. MEK 5item
  17. PORCN 1 item
  18. FGFR 3item
  19. Nrf2 1 item
  20. GABAB Receptors 1 item
  21. Smoothened 1 item
  22. MET 1 item
  23. Src 2item
  24. STAT 4item
  25. EGFR 14item
  26. Hedgehog 1 item
  27. BMP and Other Activin Receptors 2item
  28. JAK 11item
  29. Syk 2item
  30. HSP90 1 item
  31. TNKS 1 item
  32. ErbB 2item
  33. Toll-like receptors (TLRs) 1 item
  34. ERK 1 item
  35. c-MET 1 item
  36. PKC 3item
  37. HER2 2item
  38. Melanocortin (MC) Receptors 1 item
  39. Fatty-acid-binding proteins (FABPs) 1 item
  40. NO Donors / Precursors 1 item
  41. IL Receptors 1 item
  42. Insulin Receptors 1 item
  43. IRG-1R 1 item
  44. c-RET 1 item
  45. TYK2 1 item
Reported Experiments
  1. Animal Experiments 102item
  2. Cell Experiments 62item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 3item
  3. Bladder Cancer 2item
  4. Breast Cancer 25item
  5. Cancer 75item
  6. Cervical Cancer 2item
  7. Colon Cancer 9item
  8. Colon Carcinoma 1 item
  9. Colorectal Cancer 11item
  10. Glioblastoma 11item
  11. Glioma 3item
  12. Hepatocellular Carcinoma 1 item
  13. HIV Infections 1 item
  14. Immunological Diseases 1 item
  15. Inflammatory Bowel Disease 1 item
  16. Leukemia 8item
  17. Liver Cancer 2item
  18. Lung Cancer 8item
  19. Lymphoma 3item
  20. Melanoma 5item
  21. Multiple Myeloma 2item
  22. Myelofibrosis 1 item
  23. Myeloma 1 item
  24. Neuroblastoma 2item
  25. Non-small Cell Lung Cancer 6item
  26. Ovarian Cancer 7item
  27. Pancreatic Cancer 11item
  28. Pancreatic Carcinoma 2item
  29. Prostate Cancer 14item
  30. Psoriasis 1 item
  31. Pulmonary Arterial Hypertension 1 item
  32. Pulmonary Fibrosis 1 item
  33. Renal Cancer 1 item
  34. Renal Cell Carcinoma 1 item
  35. Rheumatoid Arthritis 4item
  36. Thyroid Cancer 2item
  37. Type 2 Diabetes 2item